IPP Bureau
Zydus receives approval from COFEPRIS to market? Mamitra to treat various cancers
By IPP Bureau - July 31, 2024
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Jagat Pharma launches isotine eye gummies for enhanced vision support
By IPP Bureau - July 31, 2024
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Fischer MVL and Bio Angle Vacs partner to launch livestock and aquaculture vaccines to India
By IPP Bureau - July 31, 2024
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
GSK’s RSV vaccine ‘Arexvy’ receives positive European Medicines Agency’s CHMP opinion for adults aged 50-59
By IPP Bureau - July 30, 2024
Decision on EU marketing authorisation for this population expected by September 2024
Dr. Reddy's receives positive CHMP opinion from EMA for its proposed Rituximab biosimilar
By IPP Bureau - July 30, 2024
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Pfizer Ltd. posts Q1 FY25 PAT at Rs. 150.71 Cr
By IPP Bureau - July 30, 2024
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
GSK and Flagship partner to discover novel medicines and vaccines
By IPP Bureau - July 30, 2024
GSK and Flagship to jointly fund up to $150 million upfront
Aarti Drugs posts Q1 FY25 PAT lower at Rs. 33.3 Cr
By IPP Bureau - July 30, 2024
India reiterates commitment to adolescents on launch of ‘Economic Case for Investment in the Well-being of Adolescents in India’ report
By IPP Bureau - July 29, 2024
Report highlights significant improvements in adolescent well-being in India
India established Comprehensive Lactation Management Centres for feeding low birth weight babies in ICUs
By IPP Bureau - July 29, 2024
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Steps taken by India for preparedness against future pandemics
By IPP Bureau - July 29, 2024
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr
By IPP Bureau - July 29, 2024
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
USFDA completes inspection at Biocon Biologics’ facilities in Bengaluru
By IPP Bureau - July 29, 2024
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Briefs: Indoco Remedies and Alembic Pharmaceuticals
By IPP Bureau - July 29, 2024
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
